• drapreau en
  • drapreau fr


  • Invited speakers
  • Douglas HANAHAN

    Laboratory of Translational Oncology, EPFL, ISREC, Lausanne

    M. Celeste SIMON

    Abramson Family Cancer Research Institute, University of Pennsylvania
     

    Hervé AVET-LOISEAU

    Cancer Research Center of Toulouse (CRCT)

    Madalena Tarsounas

    Genome stability and tumourigenesis, University of Oxford
     

    Yves Pommier

    Center for Cancer Research, National Cancer Institute, Bethesda

     

    Julie Guillermet

    Cancer Research Center of Toulouse (CRCT)

    Jean-Christophe Marine

    VIB-KU Leuven Center for Cancer Biology, Leuven
     

    Nikhil C. Munshi

    Dana Farber Cancer Institute, Boston

    Eric Vivier, CIML, Centre d’Immunology de Marseille-Luminy (CIML), Marseille

    Éric Vivier, DVM, PhD, is Professor of Immunology at Aix-Marseille University and at the Public Hospital of Marseille.
    Prof. Vivier was appointed Scientific Director of Innate Pharma, a biotechnology company dedicated to improving cancer treatment with innovative therapeutic antibodies that exploit the immune system.

    Eric Vivier is a graduate of the Ecole Nationale Vétérinaire de Maisons-Alfort and received his PhD in Immunology from the University of Paris XI. He completed his post-doctoral training at Harvard Medical School, then joined Aix-Marseille University as professor at the Centre d'Immunologie de Marseille-Luminy (CIML) in 1993 before becoming its director from 2008 to the end of December 2017.

    He is also one of the founders of Marseille-Immunopôle, an immunology cluster created in 2014 linking fundamental and therapeutic research, innovation and industrial development in the Aix-Marseille region.

    Eric Vivier's work focuses on the functioning of Natural killer lymphocytes (NK) and other innate lymphoid cells (ILCs). Professor Vivier has published nearly 300 scientific articles and is on the list of the most cited researchers (https://clarivate.com/hcr/ ).

    A laureate of the European Research Council (ERC advanced grants), a member of the Académie Nationale de Médecine and the Institut Universitaire de France, Prof. Vivier has received several awards including those from the Ligue Nationale contre le Cancer (1996, 2004 and 2013) and the European Federation of Immunological Societies (EFIS, 2004).

    He is also a Chevalier de la Légion d'Honneur.


    Jean-Jacques Fournié

    Cancer Research Center of Toulouse (CRCT)


     

    Christian Frezza

    MRC Cancer Unit, University of Cambridge

    Laurent Le Cam

     Institut de Recherche en Cancérologie de Montpellier (IRCM), Montpellier

    Marina Konopleva

    Department of Leukemia, MD Anderson Cancer Center, Houston